Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Cannara Biotech (TSE:LOVE)

TSXV:LOVE

LOVE

Cannara Biotech

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding TSE:LOVE?

Track your performance easily

Link Broker

Cannara Biotech (LOVE) Income Statement

26 Followers

Cannara Biotech Income Statement

Last quarter (Q3 2024), Cannara Biotech's total revenue was C$27.56M, an increase of 72.96% from the same quarter last year. In Q3, Cannara Biotech's net income was C$2.02M. See Cannara Biotech’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Aug 23	Aug 22	Aug 21	Aug 20	Aug 19
Total Revenue	C$ 92.54M	C$ 57.26M	C$ 35.48M	C$ 17.02M	C$ 2.55M	C$ 2.10M
Cost of Revenue	C$ 49.27M	C$ 30.03M	C$ 21.85M	C$ 6.72M	C$ 1.33M	C$ 403.89K
Gross Profit	C$ 43.27M	C$ 27.23M	C$ 13.63M	C$ 10.30M	C$ 1.22M	C$ 1.69M
Operating Expense	C$ 21.77M	C$ 15.21M	C$ 20.34M	C$ 10.00M	C$ 13.15M	C$ 11.92M
Operating Income	C$ 21.50M	C$ 12.02M	C$ -6.71M	C$ 299.20K	C$ -11.93M	C$ -10.22M
Net Non Operating Interest Income Expense	C$ -4.36M	C$ -5.06M	C$ -3.22M	C$ 1.67M	C$ -1.10M	C$ -847.93K
Other Income Expense	C$ 11.81M	C$ -15.32K	C$ -12.21M	C$ -154.53K	C$ -67.30K	C$ -1.90M
Pretax Income	C$ 5.32M	C$ 2.89M	C$ 2.31M	C$ -1.53M	C$ -13.09M	C$ -12.97M
Tax Provision	-	-	-	-	C$ 0.00	C$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	C$ 5.32M	C$ 2.89M	C$ 2.31M	C$ -1.53M	C$ -12.48M	C$ -12.32M
Basic EPS	C$ 0.05	C$ 0.08	C$ 0.01	C$ -1.00	C$ -0.02	C$ -0.02
Diluted EPS	C$ 0.05	C$ 0.08	C$ 0.01	C$ -1.00	C$ -0.02	C$ -0.02
Basic Average Shares	C$ 363.73M	C$ 89.30M	C$ 876.69M	C$ 7.65M	C$ 713.33M	C$ 614.84M
Diluted Average Shares	C$ 365.90M	C$ 89.30M	C$ 878.40M	C$ 7.65M	C$ 713.33M	C$ 614.84M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	C$ 343.83K	-
Total Expenses	C$ 71.04M	C$ 45.24M	C$ 42.20M	C$ -16.72M	C$ 14.48M	C$ 12.32M
Net Income From Continuing And Discontinued Operation	C$ 5.32M	C$ 2.89M	C$ 2.31M	C$ -1.53M	C$ -12.48M	C$ -12.32M
Normalized Income	C$ 2.12M	C$ 2.26M	C$ -9.43M	C$ -1.08M	C$ -12.42M	C$ -10.41M
Interest Expense	-	-	-	-	C$ 1.33M	C$ 1.51M
EBIT	C$ 10.15M	C$ 6.78M	C$ 5.62M	C$ 38.06K	C$ -11.77M	C$ -11.46M
EBITDA	C$ 16.05M	C$ 11.72M	C$ 9.54M	C$ 3.06M	C$ -9.19M	C$ -10.89M

Currency in CAD

Cannara Biotech Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing